Anthera Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (27)

Latest Posts

About This Stock More About This Stock
Anthera's Blisibimod Positive In Phase II Extension Study
Article By: Zacks Investment Research
Tuesday, August 29, 2017 1:43 PM EDT
Anthera Pharmaceuticals, Inc. announced positive top-line data from the extension of a phase II BRIGHT-SC study, evaluating key pipeline candidate, blisibimod for treatment of patients with IgA nephropathy (IgAN).
In this article: ANTH Also: LLY, ACAD, ADRO
Read
Return On Invested Capital: The Best And Worst
Article By: David Trainer
Monday, April 25, 2016 1:53 PM EDT
ROIC is the best measure of corporate performance and the primary driver of stock prices. We show the companies with the highest and lowest ROIC.
In this article: EDU, TXMD, CRDS, ANTH, AAPL, CHKP, UBNT, VEEV, MBVX, RSPI
Read
10 Top U.S. Stocks To Keep Up The 1H Winning Streak
Article By: Sweta Killa
Tuesday, June 30, 2015 8:14 AM EDT
Given the increased confidence in the U.S. economy as well as a delayed Fed rate hike, the stock market should continue to surge. Our choice of stocks will also, hopefully, be high fliers with above-market returns in the second half.
In this article: NPTN, ANTH, OXM, NTDOY, CYBR, INSY, AMBA Also: SPY, DIA, QQQ, IWM
Read
3 Biotech Stocks Under $10 With Amazing Growth Prospects
Article By: Zacks Investment Research
Wednesday, April 15, 2015 12:03 PM EDT
The biotech sector is witnessing changing dynamics with the focus shifting from large caps to smaller companies with high growth potential.
In this article: GERN, HSP, PFE, GILD, AMGN, ESRX, NVS, JNJ, ABBV, PCYC, ANTH
Read
Anthera Pharmaceuticals Inc (ANTH) Gains 35% On Phase 3 Trial Update
Article By: BioMedReports
Tuesday, February 10, 2015 4:20 PM EDT
Anthera Pharmaceuticals Inc. (ANTH) jumped a whopping 35% to $3.53 this afternoon on huge volume of 13.04 million shares as the company announced that its Phase 3 trials will continue to completion as planned.
In this article: ANTH
Read

PARTNER HEADLINES

Latest Tweets for $ANTH

No tweets yet!